Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Clovis Oncology, Inc. | 42,223 | reported | 10 Jun 2021 | tx 9+196,014 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 10+65,500−231,444 |
| Loxo Oncology, Inc. | 0 | reported | 15 Feb 2019 | tx 39+115,999−373,905 |
| Checkmate Pharmaceuticals, Inc. | 0 | reported | 31 May 2022 | tx 4+10,030−36,778 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 66,377 | — | |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 25,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 32,064 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 56,112 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 11,391 | — | deriv |
| 12 Jun 2023 | GRANT_AWARD | Kinnate Biopharma Inc. | 25,000 | 0.00 USD | deriv |
| 13 Jun 2022 | GRANT_AWARD | Kinnate Biopharma Inc. | 20,250 | 0.00 USD | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 4,012 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 22,736 | — | deriv |
| 31 May 2022 | OTHER | Checkmate Pharmaceuticals, Inc. | 10,030 | — | deriv |
| 16 Jun 2021 | GRANT_AWARD | Checkmate Pharmaceuticals, Inc. | 10,030 | 0.00 USD | deriv |
| 11 Jun 2021 | GRANT_AWARD | Kinnate Biopharma Inc. | 20,250 | 0.00 USD | deriv |
| 10 Jun 2021 | GRANT_AWARD | Clovis Oncology, Inc. | 42,223 | 0.00 USD | deriv |
| 04 Jun 2020 | GRANT_AWARD | Clovis Oncology, Inc. | 40,138 | 0.00 USD | deriv |
| 06 Jun 2019 | GRANT_AWARD | Clovis Oncology, Inc. | 28,882 | 0.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 9,732 | 235.00 USD | |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 7,812 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 7,812 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 12,500 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 15,625 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 31,459 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 68,620 | 235.00 USD | deriv |
| 15 Feb 2019 | OTHER | Loxo Oncology, Inc. | 32,345 | 235.00 USD | deriv |